<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04729361</url>
  </required_header>
  <id_info>
    <org_study_id>2021PI007</org_study_id>
    <nct_id>NCT04729361</nct_id>
  </id_info>
  <brief_title>CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction</brief_title>
  <official_title>CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to french recommandations for IUGR management we have to propose a CGH-array&#xD;
      analysis if the IUGR is severe (bellow the 3rd percentile) and early (in the second&#xD;
      trimester). However there is no data to support this point of view.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 31, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rate of abnormal CGH-array in the groupe &quot;severe and early&quot; UGR</measure>
    <time_frame>one-time (at the time of the analysis)</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>IUGR</condition>
  <condition>Prenatal Disorder</condition>
  <condition>Genetic Disease</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>CGH array analysis</intervention_name>
    <description>CGH array analysis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the third&#xD;
        percentile on CFEF curves) and early (between 21 and 24 gestational weeks).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the&#xD;
             third percentile on CFEF curves) and early (between 21 and 24 gestational weeks).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  associated IUGR (with other abnormalities during prenatal screening)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Matthieu DAP</investigator_full_name>
    <investigator_title>medical doctor (MD)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

